On Friday, Pengrowth Energy Corp (USA) (NYSE:PGH)’s shares declined -6.84% to $1.10.
Pengrowth Energy Corporation (PGH) declared that its September 15, 2015 cash dividend will be Cdn $0.02 per common share. The ex-dividend date is August 20, 2015. The dividend will be payable to all shareholders who hold Pengrowth shares at the close of business on the record date of August 24, 2015.
The dividend of Cdn $0.02 per common share is equivalent to about U.S. $0.015 per common share using a Canadian/U.S. dollar exchange rate of Cdn $1.00:U.S. $0.765. The actual U.S. dollar equivalent of the dividend will be based upon the actual Canadian/U.S. dollar exchange rate in effect on the payment date, net of applicable Canadian withholding taxes for U.S. residents who hold their Pengrowth shares in taxable accounts.
The above dividend has been designated as an “eligible dividend” for Canadian income tax purposes. Pengrowth’s dividends are also considered “qualified dividends” for U.S. income tax purposes.
Pengrowth Energy Corporation engages in the acquisition, development, exploration, and production of oil and natural gas assets in the Alberta, British Columbia, Saskatchewan, and Nova Scotia provinces in Canada. It primarily explores for crude oil, bitumen, natural gas, and natural gas liquids. The company’s assets comprise Cardium light oil, Lindbergh thermal, and Swan Hills light oil projects.
Radian Group Inc(NYSE:RDN)’s shares dropped -1.91% to $17.49.
Radian Group Inc. (RDN) stated net income for the quarter ended June 30, 2015, of $50.0 million, or $0.22 per diluted share, which comprised of the following pre-tax items: a loss of $91.9 million on induced conversion and debt extinguishment from recent actions to strengthen the company’s capital structure, and net gains of $28.4 million on investments and other financial instruments. This compares to net income for the quarter ended June 30, 2014, of $174.8 million, or $0.78 per diluted share, which comprised of pre-tax net gains of $25.3 million on investments and other financial instruments, and $71.3 million of net income from suspended operations. The company also stated an income tax provision of $34.8 million for the quarter ended June 30, 2015, contrast to an income tax benefit of $10.7 million for the quarter ended June 30, 2014.
Radian Group Inc., through its auxiliaries, provides mortgage and real estate products and services in the United States. It operates through two segments, Mortgage Insurance, and Mortgage and Real Estate Services (MRES). The Mortgage Insurance segment provides credit-related insurance coverage, principally through private mortgage insurance that protects mortgage lenders from all or a portion of default-related losses on residential mortgage loans made to home buyers, in addition to facilitates the sale of these mortgage loans in the secondary mortgage market. It offers primary mortgage insurance coverage on residential first-liens.
At the end of Friday’s trade, RR Donnelley & Sons Co (NASDAQ:RRD)‘s shares dipped -0.77% to $15.43.
RR Donnelley & Sons Company (RRD) recently declared that it intends to create three independent, publicly traded companies: one business focused on financial communications and data services; one business focused on publishing and retail-centric print services; and one business focused on customized multichannel communications administration.
Planned Benefits
- Each business to focus on its distinct planned preceding ties, driving opportunities to accelerate growth and enhance long-term value.
- Greater flexibility to execute tailored business strategies and compete in evolving markets.
- Even more focused brand strategy to support each business’s marketing plan.
R.R. Donnelley & Sons Company provides integrated communications solutions to private and public sector clients in the United States and internationally. The company operates through Publishing and Retail Services, Variable Print, Planned Services, and International segments. Its product and service offerings comprise magazines, catalogs, retail inserts, books, directories, and packaging products; commercial and digital print, direct mail, office products, labels, statement printing, and forms; and logistics services, financial print products and related services, print administration products, and digital and creative solutions.
EXACT Sciences Corporation (NASDAQ:EXAS), ended its Friday’s trading session with -4.02% loss, and closed at $20.31.
Exact Sciences Corp. (EXAS) declared that Cologuard was awarded a Wisconsin Innovation Award (WIA) in the “Healthcare/Health IT” category at the second annual ceremony held on August 18, 2015 at Discovery World in Milwaukee, Wisconsin. Cologuard was chosen from more than 170 entries and 33 finalists to receive one of 10 awards.
Cologuard is the first and only FDA approved noninvasive stool DNA screening test for colorectal cancer. It detects the presence of cancer and precancer by analyzing both DNA and blood in the stool and offers people an easy-to-use screening test, which they can do in the privacy of their own home. Unlike other screening options, Cologuard does not require medication or dietary restrictions or bowel preparation preceding to taking the test. Cologuard is accessible by prescription only through a healthcare provider.
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing non-invasive colorectal cancer screening products. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test comprises proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
